Hongyong He Selected Research

Hongyong He Research Topics

Disease

34	Stomach Neoplasms (Stomach Cancer) 11/2023 - 07/2012
25	Neoplasms (Cancer) 12/2023 - 12/2012
6	Neoplasm Metastasis (Metastasis) 10/2019 - 12/2012
3	Hepatocellular Carcinoma (Hepatoma) 06/2013 - 12/2012
2	Inflammation (Inflammations) 01/2022 - 12/2020
2	Adenocarcinoma 01/2019 - 01/2016
1	Melanoma (Melanoma, Malignant) 05/2023
1	Genomic Instability 05/2023
1	Hypersensitivity (Allergy) 12/2020
1	Infections 12/2012

Drug/Important Bio-Agent (IBA)

10	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 03/2017
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2012
4	Messenger RNA (mRNA)IBA 01/2022 - 10/2019
3	ParaffinIBA 12/2023 - 01/2020
3	Formaldehyde (Formol)FDA Link 12/2023 - 01/2020
3	pembrolizumabIBA 12/2022 - 12/2020
3	CytokinesIBA 12/2020 - 12/2016
3	ChemokinesIBA 10/2019 - 11/2014
2	Interferon-gamma (Interferon, gamma)IBA 12/2023 - 11/2020
2	Peptides (Polypeptides)IBA 01/2022 - 01/2021
2	PerforinIBA 01/2021 - 11/2020
2	CXC ChemokinesIBA 01/2021 - 01/2013
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2019 - 10/2017
2	Indicators and Reagents (Reagents)IBA 10/2017 - 08/2016
2	Small Interfering RNA (siRNA)IBA 06/2013 - 01/2013
1	ChromatinIBA 12/2023
1	RNA (Ribonucleic Acid)IBA 11/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 11/2023
1	Programmed Cell Death 1 ReceptorIBA 05/2023
1	C-Type Lectins (C-Type Lectin)IBA 01/2023
1	dectin 1IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Complement Receptors (Complement Receptor)IBA 01/2023
1	NucleotidesIBA 12/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	Hepatitis A Virus Cellular Receptor 2IBA 01/2022
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 11/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021
1	LigandsIBA 01/2021
1	APOBEC-1 DeaminaseIBA 01/2021
1	Interleukin-9 (Interleukin 9)IBA 12/2020
1	Granzymes (Granzyme)IBA 11/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020
1	Immune Checkpoint ProteinsIBA 11/2020
1	Cell Adhesion MoleculesIBA 01/2020
1	IntegrinsIBA 01/2020
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2020
1	Therapeutic UsesIBA 10/2019
1	MethyltransferasesIBA 11/2017
1	Protein MethyltransferasesIBA 11/2017
1	Interleukin-8A Receptors (Receptors, Interleukin 8A)IBA 03/2017
1	Glycoproteins (Glycoprotein)IBA 12/2016
1	Interleukin-6 (Interleukin 6)IBA 12/2016
1	Biomarkers (Surrogate Marker)IBA 09/2016
1	Galectins (Galectin)IBA 09/2016
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 08/2016
1	Chemokine CXCL12IBA 11/2014
1	Sorafenib (BAY 43-9006)FDA Link 06/2013
1	Enhancer of Zeste Homolog 2 ProteinIBA 06/2013
1	Histone MethyltransferasesIBA 06/2013
1	3-deazaneplanocinIBA 06/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2013
1	Polysaccharides (Glycans)IBA 02/2013
1	p21-Activated KinasesIBA 01/2013
1	Axitinib (AG 013736)IBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2013
1	hepatitis B virus X proteinIBA 12/2012
1	Transcription Factors (Transcription Factor)IBA 07/2012

Therapy/Procedure

11	Adjuvant Chemotherapy 05/2023 - 01/2017
9	Gastrectomy 10/2020 - 01/2016
7	Therapeutics 01/2023 - 06/2013
4	Immunotherapy 12/2023 - 01/2022
4	Lymph Node Excision (Lymph Node Dissection) 10/2020 - 12/2016
2	Drug Therapy (Chemotherapy) 12/2023 - 01/2021
1	Sutures (Suture) 01/2019